Plasma proteomic profiling: Search for lung cancer diagnostic and early detection markers

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1367-1372

  Ali, Iqbal Unnisa ^a,b   Xiao, Zhen ^a   Malone, Winfred ^a   Smith, Mylinh ^d   Conrads, Thomas P ^b   Veenstra, Timothy D ^b   Greenwald, Peter ^a   Luke, Brian T ^c   McLarty, Jerry W ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Diagnostic early detection markers; Lung cancer; Plasma proteomic profiling; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

PROTEOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; EARLY DIAGNOSIS; HUMAN; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADULT; AGED; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOME; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 33745004833     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1367     Document Type: Article

References (19)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
2. Fry WA, Phillips JL and Menck HR: Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer database report. Cancer 86: 1867-1876, 1999.
3. Corson JM: Pathology of mesothelioma. Thorac Surg Clin 14: 447-460, 2004.
4. Hughes RS: Malignant pleural mesothelioma. Am J Med Sci 329: 29-44, 2005.
5. Godleski JJ: Role of asbestos in etiology of malignant pleural mesothelioma. Thorac Surg Clin 14: 479-487, 2004.
6. Williams MD and Sandler AB: The epidemiology of lung cancer. Cancer Treat Res 105: 31-52, 2001.
7. Tweedale G: Asbestos and its lethal legacy. Nat Rev Cancer 2: 311-315, 2002.
8. Nelson HH and Kelsey KT: The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene 21: 7284-7288, 2002. (Pubitemid 35305590)
9. Lee DH and Selikoff IJ: Historical background to the asbestos problem. Environ Res 18: 300-314, 1979. (Pubitemid 9189652)
10. Lee PN: Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 58: 145-153, 2001.
11. Levin JL, McLarty JW, Hurst, GA, Smith AN and Frank AL: Tyler asbestos workers: mortality experience in a cohort exposed to amosite. Occup Environ Med 55: 155-160, 1998. (Pubitemid 28212194)
12. Von Eggeling F, Junker K, Fiedle W, et al: Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis 22: 2898-2902, 2001. (Pubitemid 32851187)
13. Yip TT and Lomas L: SELDI ProteinChip array in oncoproteomic research. Technol Cancer Res Treat 1: 273-280, 2002.
14. Hurst GA, Spivey CG, Matlage, WT, et al: The Tyler Asbestos Workers Program. I. A medical surveillance model and method. Arch Environ Health 34: 432-439, 1979. (Pubitemid 10161273)
15. Slotta DJ, Heath LS, Ramakrishnan N, Helm R and Potts M: Clustering mass spectrometry data using order statistics. Proteomics 3: 1687-1691, 2003. (Pubitemid 37129813)
16. Luke BT: An overview of genetic methods. In: Genetic Algorithms in Molecular Modeling. Devillers J (ed). Academic Press, London, pp35-66, 1996.
17. Luke BT: Genetic algorithms and beyond. In: Nature-Inspired Methods in Chemometrics: Genetic Algorithms and Neural Networks. Leardi R (ed). Elsevier, Amsterdam, pp3-54, 2003.
18. Diamandis EP: Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49: 1272-1275, 2003.
19. Diamandis EP: Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96: 353-356, 2004.